116 related articles for article (PubMed ID: 2185043)
21. Effects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment.
Biljan MM; Lapensée L; Mahutte NG; Bissonnette F; Hemmings R; Tan SL
Fertil Steril; 2000 Nov; 74(5):941-5. PubMed ID: 11056237
[TBL] [Abstract][Full Text] [Related]
22. Ovarian cysts in dairy cattle: a review.
Kesler DJ; Garverick HA
J Anim Sci; 1982 Nov; 55(5):1147-59. PubMed ID: 6757234
[TBL] [Abstract][Full Text] [Related]
23. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
24. [A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization].
Ye H; Huang G; Pei L
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):222-5. PubMed ID: 11783366
[TBL] [Abstract][Full Text] [Related]
25. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
Usui A
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
[TBL] [Abstract][Full Text] [Related]
26. [Increased incidence of ovarian hyperstimulation syndrome following combined GnRH agonist/hMG therapy].
Lindner C; Braendle W; Köhler S; Bettendorf G
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):337-44. PubMed ID: 2525500
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
28. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
29. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
[TBL] [Abstract][Full Text] [Related]
30. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
Sherman BM; Chapler FK; Crickard K; Wycoff D
J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
[TBL] [Abstract][Full Text] [Related]
31. Induction of multiple ovulation by pulsatile administration of gonadotropin-releasing hormone.
Liu JH; Durfee R; Muse K; Yen SS
Fertil Steril; 1983 Jul; 40(1):18-22. PubMed ID: 6345206
[TBL] [Abstract][Full Text] [Related]
32. Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF.
Fujii S; Sato S; Fukui A; Kimura H; Kasai G; Saito Y
Hum Reprod; 2001 Aug; 16(8):1671-5. PubMed ID: 11473961
[TBL] [Abstract][Full Text] [Related]
33. Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy.
Feldberg D; Ashkenazi J; Dicker D; Yeshaya A; Goldman GA; Dicker D; Goldman JA
Fertil Steril; 1989 Jan; 51(1):42-5. PubMed ID: 2521325
[TBL] [Abstract][Full Text] [Related]
34. Flexible menotropins initiation after long-acting gonadotropin-releasing hormone analog.
Ron-el R; Golan A; Herman A; Raziel A; Nachum H; Caspi E
Fertil Steril; 1989 Nov; 52(5):860-3. PubMed ID: 2509255
[TBL] [Abstract][Full Text] [Related]
35. Outcome of ovarian response after suppression with a gonadotropin releasing hormone agonist in different chronological periods prior to gonadotropin stimulation for in vitro fertilization.
Loutradis D; Kallianidis K; Sakellaropoulos G; Dokos J; Siskos K; Creatsas G; Deligeoroglou E; Michalas S; Aravantinos D
Gynecol Obstet Invest; 1991; 32(2):68-71. PubMed ID: 1748325
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
de Jong D; Macklon NS; Eijkemans MJ; Mannaerts BM; Coelingh Bennink HJ; Fauser BC;
Fertil Steril; 2001 Apr; 75(4):688-93. PubMed ID: 11287020
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
Herman A; Ron-El R; Golan A; Raziel A; Soffer Y; Caspi E
Fertil Steril; 1990 Jan; 53(1):92-6. PubMed ID: 2104811
[TBL] [Abstract][Full Text] [Related]
38. Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization.
Brzyski RG; Jones GS; Jones HW; Oehninger S; Muasher SJ
Fertil Steril; 1991 Jan; 55(1):119-24. PubMed ID: 1898886
[TBL] [Abstract][Full Text] [Related]
39. Significance of an abnormal response during pituitary desensitization in an in vitro fertilization and embryo transfer program.
Goswami SK; Chakravarty BN; Kabir SN
J Assist Reprod Genet; 1996 May; 13(5):374-80. PubMed ID: 8739051
[TBL] [Abstract][Full Text] [Related]
40. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
